Showing results (121-130 of 134) with videos related to
Sort By:
Pageof 14
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 13, 2025
NAD⁺ Reduction in Glutamatergic Neurons Induces Lipid Catabolism and Neuroinflammation in the Brain via SARM1Zhen-Xian Niou, Sen Yang, Andrea Enriquez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011Vicki A Morrison, Kanti R Rai, Bercedis L Peterson, et al.Blood|May 13, 2004
Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011John C Byrd, Kanti Rai, Bercedis L Peterson, et al.Blood|April 15, 1992
Varying intensity of postremission therapy in acute myeloid leukemiaP A Cassileth, E Lynch, J D Hines, et al.Oncology|January 1, 1985
Combination chemotherapy prior to definitive local therapy in squamous cell carcinoma of the head and neckD J Adelstein, J D Hines, V M Sharan, et al.Cardiovascular Research|October 20, 2019
Pharmacological activation of IKr in models of long QT Type 2 risks overcorrection of repolarizationMatthew D Perry, Chai-Ann Ng, Melissa M Mangala, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1987
Cerebellar toxicity with high-dose cytosine arabinosideR H Herzig, J D Hines, G P Herzig, et al.Leukemia|January 1, 1992
Escalating the intensity of post-remission therapy improves the outcome in acute myeloid leukemia: the ECOG experience. The Eastern Cooperative Oncology GroupP A Cassileth, J W Andersen, J M Bennett, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B StudyP J O'Dwyer, J Manola, F H Valone, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
Impact of therapy With chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011V A Morrison, K R Rai, B L Peterson, et al.Pageof 14